References
1. Pariente B, Cosnes J, Danese S et al. Development of the Crohn’s disease digestive damage score, the Lémann score. Inflamm Bowel Dis 2011;17:1415–22. DOI: 10.1002/ibd.21506
2. Rutgeerts P, Geboes K, Vantrappen G et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology 1990;99:956–63. doi: S0016508590003596 [pii]
3. Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Special situations. Journal of Crohn’s and Colitis 2010; 4:63-101. DOI: 10.1016/j.crohns.2009.09.009
4. De Cruz P, Kamm MA, Prideaux L et al. Postoperative recurrent luminal Crohn’s disease: A systematic review. Inflamm Bowel Dis 2012;18:758–77. DOI: 10.1002/ibd.21825
5. Schwartz M, Regueiro M. Prevention and treatment of postoperative Crohn’s disease recurrence: An update for a new decade. Curr Gastroenterol Rep 2011;13:95–100. DOI: 10.1007/s11894-010-0152-x
6. Sorrentino D. State-of-the-art medical prevention of postoperative recurrence of Crohn’s disease. Nat Rev Gastroenterol Hepatol 2013;10:413–22. DOI: 10.1038/nrgastro.2013.69
7. Sandborn WJ, Hanauer S, Van Assche G, et al. Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases. J Crohn’s Colitis. European Crohn’s and Colitis Organisation 2014;8:927–35. DOI: 10.1016/j.crohns.2014.02.021
8. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology 1995;108:1617–21. DOI: 10.1016/0016-5085(95)90121-3
9. Peyrin-Biroulet L, Deltenre P, Ardizzone S, et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Am J Gastroenterol 2009;104:2089–96. DOI: 10.1038/ajg.2009.301
10. Carla-Moreau A, Paul S, Roblin X, et al. Prevention and treatment of postoperative Crohn’s disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials. Dig Liver Dis 2015;47:191–6. DOI: 10.1016/j.dld.2014.11.005
11. Domènech E, Mañosa M, Bernal I et al. Impact of azathioprine on the prevention of postoperative Crohn’s disease recurrence: Results of a prospective, observational, long-term follow-up study. Inflamm Bowel Dis 2008;14:508–13. DOI: 10.1002/ibd.20359
12. De Cruz P, Kamm MA, Hamilton AL et al. Crohn’s disease management after intestinal resection: a randomised trial. Lancet 2015;385:1406-17. DOI: 10.1016/S0140-6736(14)61908-5 DOI: 10.1016/S0140-6736(14)61908-5
13. Ferrante M, Papamichael K, Duricova D et al. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn’s Disease Recurrence. J Crohn’s Colitis 2015;9:617–24. DOI: 10.1093/ecco-jcc/jjv076
14. Baudry C, Pariente B, Lourenço N et al. Tailored treatment according to early post-surgery colonoscopy reduces clinical recurrence in Crohn’s disease: A retrospective study. Dig Liver Dis 2014;887–92. DOI: 10.1016/j.dld.2014.07.005
15. González Lama Y. Impact of Endoscopic monitoring in postoperative Crohn’s disease patients already receiving pharmacological prevention of recurrence. Rev Esp Enferm Dig. 2015 Jul 14;107. DOI: 10.17235/reed.2015.3836/2015